These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9602410)

  • 1. End-stage renal disease projections for Canada to 2005 using Poisson and Markov models.
    Schaubel DE; Morrison HI; Desmeules M; Parsons D; Fenton SS
    Int J Epidemiol; 1998 Apr; 27(2):274-81. PubMed ID: 9602410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. End-stage renal disease in Canada: prevalence projections to 2005.
    Schaubel DE; Morrison HI; Desmeules M; Parsons DA; Fenton SS
    CMAJ; 1999 Jun; 160(11):1557-63. PubMed ID: 10373996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New and prevalent patients with end-stage renal disease in Canada. A portrait of the year 2000.
    Desmeules M; Schaubel D; Fenton SS; Mao Y
    ASAIO J; 1995; 41(2):230-3. PubMed ID: 7640434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projecting prevalence, costs and evaluating simulated interventions for diabetic end stage renal disease in a Canadian population of aboriginal and non-aboriginal people: an agent based approach.
    Gao A; Osgood ND; Jiang Y; Dyck RF
    BMC Nephrol; 2017 Sep; 18(1):283. PubMed ID: 28870154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markov Chain Monte Carlo simulation for projection of end stage renal disease patients in Greece.
    Rodina-Theocharaki A; Bliznakova K; Pallikarakis N
    Comput Methods Programs Biomed; 2012 Jul; 107(1):90-6. PubMed ID: 22024418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projecting the number of patients with end-stage renal disease in the United States to the year 2015.
    Gilbertson DT; Liu J; Xue JL; Louis TA; Solid CA; Ebben JP; Collins AJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3736-41. PubMed ID: 16267160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Projecting demands for renal replacement therapy in the Northern Territory: a stochastic Markov model.
    You J; Zhao Y; Lawton P; Guthridge S; McDonald SP; Cass A
    Aust Health Rev; 2018 Aug; 42(4):380-386. PubMed ID: 28553999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.
    Stewart JH; McCredie MR; Williams SM; Jager KJ; Trpeski L; McDonald SP;
    Nephrology (Carlton); 2007 Oct; 12(5):520-7. PubMed ID: 17803478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forecast of the incidence, prevalence and burden of end-stage renal disease in Nanjing, China to the Year 2025.
    Sun L; Zou LX; Han YC; Huang HM; Tan ZM; Gao M; Ma KL; Liu H; Liu BC
    BMC Nephrol; 2016 Jun; 17(1):60. PubMed ID: 27295981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
    McDonald SP; Russ GR; Kerr PG; Collins JF;
    Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-years trends in renal replacement therapy for end-stage renal disease in mainland France: Lessons from the French Renal Epidemiology and Information Network (REIN) registry.
    Vigneau C; Kolko A; Stengel B; Jacquelinet C; Landais P; Rieu P; Bayat S; Couchoud C;
    Nephrol Ther; 2017 Jun; 13(4):228-235. PubMed ID: 28161264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
    Prodjosudjadi W
    Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002.
    ; Stewart JH; McCredie MR; Williams SM
    Nephrol Dial Transplant; 2006 Aug; 21(8):2178-83. PubMed ID: 16595584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009.
    Butler AM; Olshan AF; Kshirsagar AV; Edwards JK; Nielsen ME; Wheeler SB; Brookhart MA
    Am J Kidney Dis; 2015 May; 65(5):763-72. PubMed ID: 25662835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010.
    Xue JL; Ma JZ; Louis TA; Collins AJ
    J Am Soc Nephrol; 2001 Dec; 12(12):2753-2758. PubMed ID: 11729245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney Failure and ESRD in the Atherosclerosis Risk in Communities (ARIC) Study: Comparing Ascertainment of Treated and Untreated Kidney Failure in a Cohort Study.
    Rebholz CM; Coresh J; Ballew SH; McMahon B; Whelton SP; Selvin E; Grams ME
    Am J Kidney Dis; 2015 Aug; 66(2):231-9. PubMed ID: 25773483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. End-stage renal disease in India and Pakistan: burden of disease and management issues.
    Sakhuja V; Sud K
    Kidney Int Suppl; 2003 Feb; (83):S115-8. PubMed ID: 12864888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End-stage renal disease in the Asian-Pacific region.
    Lee G
    Semin Nephrol; 2003 Jan; 23(1):107-14. PubMed ID: 12563605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.